Table 1 Clinical and biochemical characteristics of the study patients.
All subjects | Without AAC | With AAC | p-value | |
|---|---|---|---|---|
Patients (n) | 101 | 46 | 55 | — |
Age (years) | 61 ± 11 | 58 ± 11 | 64 ± 10 | 0.01 |
Body weight (kg) | 59.5 ± 9.5 | 60.4 ± 10.6 | 58.8 ± 8.5 | 0.40 |
Body mass index (kg/m2) | 21.8 ± 3.0 | 21.8 ± 3.4 | 21.8 ± 2.6 | 0.99 |
Percentage body fat (%) | 21.5 ± 7.0 | 21.4 ± 7.5 | 21.5 ± 6.7 | 0.99 |
Hemodialysis duration (years) | 6.8 ± 2.9 | 6.6 ± 2.9 | 6.9 ± 2.9 | 0.65 |
Diabetes mellitus (n[%]) | 42 [42] | 10 [22] | 32 [58] | <0.001 |
Corrected calcium (mg/dL) | 9.6 ± 0.7 | 9.6 ± 0.7 | 9.6 ± 0.8 | 0.57 |
Phosphate (mg/dL) | 5.6 ± 1.1 | 5.6 ± 1.2 | 5.5 ± 1.1 | 0.54 |
Intact PTH (pg/mL) | 108 (46–204) | 139 (47–204) | 100 (39–229) | 0.78 |
hs-CRP (μg/dL) | 113 (40–382) | 73 (28–288) | 122 (48–509) | 0.07 |
Adiponectin (μg/mL) | 17.0 (11.3–24.9) | 15.4 (8.9–22.8) | 18.8 (13.0–28.1) | 0.03 |
Leptin (ng/mL) | 4.3 (2.5–8.7) | 4.2 (2.3–8.5) | 4.7 (2.5–9.6) | 0.77 |
